»» Searching for " Pharmaceuticals "
 Related Search Tags:  Merck Nasdaq:THLD THLD Threshold Magellan Nasdaq:MGLN MGLN Behavioral Idera IDRA Nasdaq:IDRA Apricus APRI Nasdaq:APRI Dexrazoxane Aegerion AEGR Nasdaq:AEGR Lomitapide LDL-C ZOLL ALNY INCY Nasdaq:ZOLL Nasdaq:ALNY Nasdaq:INCY VRUS EDGR AEN Nasdaq:VRUS Nasdaq:EDGR Amex:AEN VPF MGAM SLXP Nasdaq:VPF Nasdaq:MGAM Nasdaq:SLXP URI RJET NAVB NYSE:URI Nasdaq:RJET Amex:NAVB CalAmp TSRA BPAX Nasdaq:TSRA Nasdaq:CAMP Nasdaq:BPAX CLWR PEIX TSPT Nasdaq:CLWR NASDAQ:PEIX Nasdaq:TSPT SYNO YMI ALXA Nasdaq:SYNO Amex:YMI Nasdaq:ALXA
Showing Results 1-12 of 36 |  Sort by:     
Page 1 of 3  |  Go to page    Next» LAST»»
CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones.rnrn***********************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer). rn
Threshold Pharmaceuticals...
Categories: Videos 
Added: 108 days ago
By: karmastock
Runtime: 1m34s
Views: 31
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to watch. I am Sara Bryant. The Louisiana Department of Health and Hospitals has recommended that Magellan Health Services Incorporated - symbol MGLN - be awarded a contract to manage behavioral health care for Medicaid recipients and other beneficiaries through the Louisiana Behavioral Health Partnership. The contract with Magellan begins on March 1, 2012, and extends until February 28, 2014, with an optional one-year extension and it is expected to generate annual revenue of approximately $150 million. Magellan is a leading specialty health care management organization with expertise in managing behavioral health, radiology and specialty pharmaceuticals, as well as public sector pharmacy benefits programs. More information about Magellan Health Services at www.MagellanHealth.com. Thanks for joining me and stay with us! For CRWE Newswire, Stocks to Watch, I’m Sara Bryant
Magellan Health Services...
Categories: Videos 
Added: 262 days ago
By: karmastock
Runtime: 1m16s
Views: 78
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to watch. I am Shalika Jayasekera. Idera Pharmaceuticals Incorporated - symbol IDRA - reported that it has raised $9.5 million in a convertible preferred stock offering. Idera intends to use the net proceeds from the transaction for general corporate purposes, including continuing to fund development of its Toll-like Receptor targeted candidates, being developed to treat autoimmune and inflammatory diseases, cancer, and for use as vaccine adjuvants, and its gene-silencing oligonucleotide technology. More information about Idera Pharmaceuticals Incorporated - symbol IDRA - at iderapharma.com. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
Idera Pharmaceuticals...
Categories: Videos 
Added: 199 days ago
By: karmastock
Runtime: 1m14s
Views: 54
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. According to a a definitive agreement between the companies, Apricus Biosciences Inc - APRI - will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy—the leakage of chemotherapy drugs from veins into surrounding tissues. This complication is known as anthracycline extravasation, and can lead to infections and tissue death. With this acquisition, Apricus Biosciences will move into the commercialization and sales of oncology and oncology supportive care pharmaceuticals. Apricus Biosciences is a revenue-generating, specialty pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
Apricus Biosciences (APRI)...
Categories: Videos 
Added: 156 days ago
By: karmastock
Runtime: 1m21s
Views: 42
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Aegerion Pharmaceuticals Incorporated - AEGR - provided a clinical update on its lomitapide. Aegerion reported that the 78-week data from its pivotal Phase III clinical trial is consistent with data previously reported at the 26- and 56-week time points. According to the company, the data demonstrate that the reduction in LDL-C cholesterol from baseline was maintained at 78-weeks. Aegerion Pharmaceuticals’ Lomitapide is being evaluated for its ability to reduce low density lipoprotein (LDL-C) or bad cholesterol levels in patients with homozygous familial hypercholesterolemia. Aegerion Pharmaceuticals aspires to change the way rare, genetic lipid disorders are treated. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekerarnrn***********rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
Aegerion (AEGR) Clinical...
Categories: Videos 
Added: 135 days ago
By: karmastock
Runtime: 1m12s
Views: 36
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch for Thursday November 17th, 2011. I am Shalika Jayasekera. On its Fourth quarter fiscal 2011, ZOLL Medical Corp - symbol ZOLL - posted Record revenues of $151.9 million, a 26% increase year over year, and Net income of $11.9 million, increased 65% compared to the same period the prior year. Alnylam Pharmaceuticals Inc - symbol ALNY - has granted to Sylentis, S.A. a non-exclusive option for a new target-specific InterfeRx license. Upon Sylentis’ exercise of this option, Alnylam would receive upfront and milestone payments, as well as royalties on sales of products covered by the licensing agreement. and finally; Incyte Corp - symbol INCY - reported that the FDA has granted marketing approval for Jakafi for the treatment of patients with intermediate or high-risk myelofibrosis. Jakafi is the first and only product to be approved by the FDA for Myelofibrosis.
(ZOLL, ALNY, INCY)...
Categories: Videos 
Added: 187 days ago
By: karmastock
Runtime: 1m38s
Views: 44
 | Comments: 0
Not yet rated
Good Morning, Its Monday November 21st, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. Gilead Sciences and Pharmasset Incorporated - symbol VRUS - have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash. EDGAR Online Incorporated - symbol EDGR - has increased revenue growth guidance to be in excess of 35 percent in 2011 over 2010. and lastly; Adeona Pharmaceuticals Incorporated - symbol AEN - and the Human Therapeutics Division of Intrexon Corporation reported the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon’s UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension. Thanks for joining me and have a great week! For CRWE Newswire, Stocks In Action, I’m Christina Collins
(VRUS, EDGR, AEN)...
Categories: Videos 
Added: 183 days ago
By: karmastock
Runtime: 1m22s
Views: 65
 | Comments: 0
Not yet rated
Good Morning, Its Thursday November 17th, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. Pursuant to the terms of a definitive merger agreement, CTS Corporation will acquire 100% of the issued and outstanding equity of Valpey-Fisher Corporation - symbol VPF - for $4.15 per share in cash. Multimedia Games Holding Company Incorporated - symbol MGAM - reported operating results for its fiscal 2011 fourth quarter, posting revenue of $35.7 million, a 17.3% increase year over year. and lastly; Salix Pharmaceuticals Limited - symbol SLXP - reported that the Gastrointestinal Drugs Advisory Committee of the FDA supports the Salix/FDA developed proposed design of a clinical trial to evaluate the safety, efficacy and durability of response with repeat treatment cycles of XIFAXAN for irritable bowel syndrome with diarrhea. Thanks for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins
(VPF, MGAM, SLXP)...
Categories: Videos 
Added: 187 days ago
By: karmastock
Runtime: 1m24s
Views: 51
 | Comments: 0
Not yet rated
On its fourth quarter fiscal 2011, United Rentals Inc - URI -, posted total revenues of $746 million compared with $597 million in the same period the prior year. Republic Airways Holdings Inc - RJET - has raised its guidance for year over year unit revenue increases on its Frontier Airlines branded operations for the Fourth Quarter of 2011. Navidea Biopharmaceuticals Inc - NAVB - reported that it has entered into an option agreement with Alseres Pharmaceuticals Incorporated to License Parkinson’s Disease Imaging Agentrnrn*********************************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
(URI, RJET, NAVB)...
Categories: Videos 
Added: 117 days ago
By: karmastock
Runtime: 1m15s
Views: 44
 | Comments: 0
Not yet rated
Good Morning, Its Wednesday November 16th, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. Tessera Technologies Incorporated - symbol TSRA - reported that Samsung Electronics Company Limited has exercised its right to renew its licensing agreement with Tessera through May 2017. CalAmp Corporation - symbol CAMP - reported that it was awarded a $4.7 million extension of its development contract to help design and supply initial radios for the North American interoperable Positive Train Control system. and lastly; BioSante Pharmaceuticals Incorporated - symbol BPAX - announced results from its principal LibiGel pharmacokinetic study. The study results indicate that LibiGel (testosterone gel) increases levels of free testosterone which is the active testosterone component in the serum of postmenopausal women to within the normal ranges for younger, premenopausal women. Thanks for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins
(TSRA, CAMP, BPAX)...
Categories: Videos 
Added: 188 days ago
By: karmastock
Runtime: 1m23s
Views: 64
 | Comments: 0
Not yet rated
Good Morning, Its Thursday December 1st, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. Transcept Pharmaceuticals Incorporated - symbol TSPT - reported that Purdue has exercised its option to commercialize Intermezzo in the United States. Pacific Ethanol Incorporated - symbol PEIX - has purchased an additional 7% ownership interest in New PE Holdco LLC, the owner of the four Pacific Ethanol production facilities with a combined annual production capacity of 200 million gallons. and lastly; Sprint Nextel and Clearwire Corporation - symbol CLWR - reported agreements potentially worth up to $1.6 billion over the next four years in payments for WiMAX services, possible pre-payments for LTE services and potential equity investments. Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins
(TSPT, PEIX, CLWR)...
Categories: Videos 
Added: 173 days ago
By: karmastock
Runtime: 1m17s
Views: 49
 | Comments: 0
Not yet rated
Good Morning, It’s Tuesday December 13th, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. According to a definitive agreement between the companies, Baxter International will acquire Synovis Life Technologies Inc - SYNO - at an offer price of $28 per share. YM BioSciences Inc - YMI - reported updated results from the ongoing Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis. CYT387 was well tolerated, with dosing up to and exceeding two years. and lastly; Alexza Pharmaceuticals Inc -ALXA - reported that the FDA Psychopharmacologic Drugs-Advisory Committee voted to recommend that ADASUVE be approved for use as a single dose in 24 hours when used with the FDA recommended Risk Evaluation and Mitigation Strategy, for the treatment for agitation in patients with schizophrenia or bipolar mania. Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins
(SYNO, YMI, ALXA)...
Categories: Videos 
Added: 161 days ago
By: karmastock
Runtime: 1m25s
Views: 32
 | Comments: 0
Not yet rated
Page 1 of 3  |  Go to page    Next» LAST»»
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0551 seconds.